COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Séché Environnement and Waga Energy start up a RNG production unit in North of France
Séché Environnement and Waga Energy establish a RNG production unit at Opal Environnement site in Northwestern France, providing renewable gas to households and businesses through innovative WAGABOX® technology -
COMMUNIQUÉ DE PRESSE
Ideon Media’s 29Secrets Celebrates ‘The Story Of’ Column Win at the Canadian Online Publishing Awards
Ideon Media wins 'Best Blog Column/Videocast/Podcast' at Canadian Online Publishing Awards for 'Story Of' column by Christopher Turner on 29Secrets.com, showcasing excellence in Canadian digital publishing -
COMMUNIQUÉ DE PRESSE
N. China's Cangzhou Enjoys Notable Outcomes Following Decade of Beijing-Tianjin-Hebei Region Coordinated Development
Cangzhou, a city in north China's Hebei Province, achieves remarkable development in industry, innovation, and transportation, focusing on high-quality development in various aspects -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: BayWa AG: Board of Management resolves proposal to suspend dividend
BayWa AG's Board of Management resolves to propose suspension of dividend payment for financial year 2023 to strengthen equity base despite satisfactory operating performance. Results to be published on 28 March 2024 -
COMMUNIQUÉ DE PRESSE
The Los Angeles Hand-Up Award Gala Served a Night to Remember as Celebrities, Dignitaries, and Government Officials Came Together as Advocates for Disabilities
Los Angeles power couple recognized by government leaders at the Colin Matthew $50,000 Hand-Up Award Gala for their dedication to supporting individuals with disabilities -
-
COMMUNIQUÉ DE PRESSE
South Pacific Metals Corp. Announces Proposed Shares for Debt Transaction with Convertible Debenture Holders
South Pacific Metals Corp. announces completion of shares for debt transaction to settle outstanding debt. Insider participation highlighted. Company enhances balance sheet -
-
COMMUNIQUÉ DE PRESSE
Newron enters into an agreement for the subscription of up to 2.05 million newly issued shares; Proceeds of up to EUR 15.0 million
Newron Pharmaceuticals S.p.A. enters a subscription agreement for up to 2.05 million new shares, aiming to raise EUR 15.0 million. The investment supports CNS therapies development
